Gerresheimer Group Pharmaceutical Plastic and Glass Packaging

Drugs are not intended to fall into the hands of children. However, in case this ever happens, it is essential to restrict them from being able to open the receptacles by fastening them with child-resistant caps.

The Gx Elite vials and Gx RTF vials will be setting a new standard for type I vials made from borosilicate glass at booth 111B10 at CPhl Worldwide in Frankfurt from 5-7 November.

Gerresheimer in Essen produces many millions of glass containers for the pharmaceutical industry every year. The long-established company has recently completed the routine renovation of its clear-glass furnace.

Gerresheimer is driving innovation in pharmaceutical glass, primary packaging glass products, technologies and digitised processes.

The 2.25 ml COP (cyclic olefin polymer) SIN (staked in needle) will begin production in September 2019.

Sensile Medical has developed a wearable micro-infusion pump for EVER Pharma under the brand name D-mine®.

At FCE Pharma in São Paulo, Gerresheimer will be showcasing a complete solution for packaging effervescent vitamin C tablets, which are currently seeing strong demand.

Gerresheimer has announced it will showcase innovative primary packaging and drug administration systems at CPhl North America.

Gerresheimer will reveal its first snap-on cap with child-resistant (CR) solution at booth B62 at this year's Pharmapack.

Portal Instruments and Gerresheimer have announced they will be presenting a joint presentation titled: 'New Meets Old: Challenges and Solutions with Developing a Custom Primary Container'.

In July of this year, Gerresheimer acquired Sensile Medical, expanding its business model to become an original equipment manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities.

The Gx Elite vials have set new standards for Type 1 borosilicate glass vials. They are the result of comprehensive optimisation measures in the conversion process, which have focused on designing out the risk to create product flaws during production, including the removal of all glass-to-glass or glass-to-metal-contact beginning with the tubing material all the way through final packaging.

Gerresheimer has announced it is expanding its range of services to include surface finishing of plastic packaging for ophthalmology and rhinology products with irradiation.

By acquiring Switzerland-based Sensile Medical in July this year, Gerresheimer is expanding its business model to become an original equipment manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities.

Gerresheimer Gx Solutions is developing packaging solutions for the complex injectable drugs of tomorrow.

Gerresheimer develops and produces innovative drug delivery systems and medical and diagnostic products for prestigious international customers.

With a total of 13 sites across Asia for its range of glass and plastic products, Gerresheimer has announced it will be attending the Medipharm Expo this month.

Gerresheimer has announced it expects increased growth and profitability mid-term due to two new major orders with temporarily higher capital index (capex) / organic revenue guidance 2018 narrowed to the upper end of the range.

Gerresheimer is presenting new products such as the Gx InnoSafe, the metal-free ready-to-fill (RTF) syringe, and RTF vials at the CPhI China trade fair in Shanghai.

Gerresheimer has announced that is has expanded its production capabilities at its plastic primary packaging manufacturing site in Anápolis, Goiás, Brazil.

Gerresheimer’s Indian plants produce glass vials, ampoules and bottles that are specially designed for the storage of high-quality drugs.

Gerresheimer has announced it will be attending CPhI South East Asia, where it will be showcasing a range of innovations and company news, including the opening of its new tubular glass production plant in India for producing MultiShell vials.

Gerresheimer’s booth at the PDA Annual Meeting will focus on innovative glass and plastic vials for parenteral drugs that place high demands on the barrier properties and the safety of their primary packaging.

Gerresheimer offers pharmaceutical and medical technology products of plastics and glass in its medical systems business unit.

The Gx Elite vials are type I vials that meet high standards. Made from borosilicate glass, the vials prevent any glass-to-glass and glass-to-metal contact. The chemical composition of the borosilicate glass is still the same. Gerresheimer will be showcasing its Gx Elite vials at booth 36 at the PDA in Rome on February 27 and 28. 

Gerresheimer has announced will be presenting its Duma Standard CR container, which features Handy Cap CR at Pharmapack.

Gerresheimer has announced it will be attending the Pharma Expo Dhaka trade fair in Bangladesh, focusing on pharmaceutical primary packaging made from glass.

Dr Lukas Burkhardt has been appointed to the management board of Gerresheimer effective 1 January.

Gerresheimer will present their passive integrated safety system for avoiding needlestick injuries at Pharmapack in Paris.

Gerresheimer has announced it will be showcasing glass and plastic pharmaceutical packaging products that are Food and Drug Administration (FDA) registered and manufactured to stringent quality standards to the trade public at CPhI in Mumbai, India.  

Gerresheimer has announced that production of its US dropper bottles with a fixed TE-ring will be operational in Q3.

Gerresheimer Medical Systems has announced it will be attending the Compamed trade fair in Düsseldorf

Gerresheimer will be presenting its new type 1 borosilicate glass vial, Gx Elite, at CPhI Worldwide.

With their exposed cannulas, used syringes are an omnipresent source of danger in medical practices, labs, or hospitals.

One of the most talked-about highlights from Gerresheimer's LuxePack trade fair showcase is opal glass.

Gerresheimer is pleased to announce it will be showcasing for the first time at this year's the Pack Expo trade fair, which is due to take place from 27-29 September in Las Vegas, Nevada.

Gerresheimer is pleased to announce it will be showcasing its tubular glass packaging at the Pharmed & Healthcare event from 20-23 September in Ho Chi Minh City, Vietnam.

Gerresheimer is delighted to announce it was presented with the Best Supplier Award from its business partner Mäurer & Wirtz last month.

Gerresheimer has released the first eco-friendly plastic containers for pharmaceutical and cosmetic applications, BioPack.

Gerresheimer AG sustained its successful trend through the third quarter of the financial year.

Gerresheimer AG has successfully wrapped up its refinancing with the launch of a debt issue (Schuldschein) for a total amount of €425m.

Temperature peaks in the manufacturing process are the main cause of delamination in tubular glass vials, which was discovered in a long-term study conducted by Gerresheimer AG and the Alfred University in New York.

People who use eye drops know how difficult they are to put in safely without assistance.

Developers at Gerresheimer believe in making good products better, and are presenting an improved Duma Twist-Off container called Duma Twist-Off Advanced for solid pharmaceuticals.

Gerresheimer is one of only a few companies in the world to offer its customers both glass and COP syringes.

Gerresheimer has developed an interface for the integration of glass syringes in autoinjectors. It has now filed a patent application for its Gx G-Fix standard adapter for precise and reliable positioning of syringes.

The first time that most of us see a syringe and needle we are small babies and our mothers have taken us to the doctor to be vaccinated. Yet it is isn't just children who need vaccinations. For some diseases, we have to get vaccinated again as adults because the original vaccinations stop being effective after 20 years or so.

The new Gx MultiShell Plastic Vials overcome the specific limitations of plastic vials and combine superior properties of plastic and glass containers to a high-end container for parenterals.

The American Academy of Ophthalmology endorses the uniform use of a colour-coding system for caps and labels on topical ocular medications. Topical medications are applied locally, for example eye drops and nasal drops.

Glass ampoules are ideal as a packaging for many cosmetic and pharmaceutical products. Gerresheimer incorporates its many years of experience in the meticulous production of ampoules to guarantee that they are safe to use and always in optimum quality.

At this year's INTERPHEX, which will take place 20-22 April at the Jacob K Javits Convention Center in New York, Gerresheimer Plastic Packaging will be exhibiting its range of pharmaceutical plastic packaging products. Gerresheimer specialises in pharmaceutical and healthcare containers

Tubular glass, moulded glass, plastic, intelligent syringe systems, high-quality vials and bottles, smart safety and application solutions: the whole world of pharma packaging was united in the Gerresheimer Group at Pharmtech Moscow, which was held at the Crocus Expo Center 24–27 November 2009. G

The Gerresheimer Group recently expanded its activities in the pharmaceutical plastic business, through two strategically significant investments in the US and Europe. In September 2009 the company almost simultaneously opened a new research and development centre for medical plastic systems in t

Gerresheimer receives the WorldStar for innovative pharma closures New standards for safety and economy Nomination for the President's Award For a highly innovative pharma closure system under the Duma trademark, Gerresheimer after receiving the 2007 German Packaging

Everything from a single source for the pharmaceutics industry: the Gerresheimer Group again consistently builds on this principle in its plastic packaging business. The latest result of this development is a new tamper-evident closure system for tablet containers, which Gerresheimer manufactures